Compile Data Set for Download or QSAR
maximum 50k data
Found 362 with Last Name = 'bartane bodor' and Initial = 'v'
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249581(US9447038, 9)
Affinity DataIC50:  11nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249658(US9447038, 86)
Affinity DataIC50:  12nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166453(US9073853, 12)
Affinity DataIC50:  13nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166545(US9073853, 104)
Affinity DataIC50:  15nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166446(US9073853, 5)
Affinity DataIC50:  19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249583(US9447038, 11)
Affinity DataIC50:  19nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166528(US9073853, 87)
Affinity DataIC50:  19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249763(US9447038, 191)
Affinity DataIC50:  20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166447(US9073853, 6)
Affinity DataIC50:  20nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249609(US9447038, 37 | US9447038, 38)
Affinity DataIC50:  20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249608(US9447038, 36)
Affinity DataIC50:  20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166475(US9073853, 34)
Affinity DataIC50:  22nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249615(US9447038, 43)
Affinity DataIC50:  23nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249577(US9447038, 5)
Affinity DataIC50:  23nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166529(US9073853, 88)
Affinity DataIC50:  23nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249647(US9447038, 75)
Affinity DataIC50:  25nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166466(US9073853, 25)
Affinity DataIC50:  25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166455(US9073853, 14)
Affinity DataIC50:  25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166589(US9073853, 148)
Affinity DataIC50:  26nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166477(US9073853, 36)
Affinity DataIC50:  28nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249720(US9447038, 148)
Affinity DataIC50:  28nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249696(US9447038, 124)
Affinity DataIC50:  30nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249760(US9447038, 188)
Affinity DataIC50:  31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249659(US9447038, 87)
Affinity DataIC50:  31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249601(US9447038, 29)
Affinity DataIC50:  31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166450(US9073853, 9)
Affinity DataIC50:  32nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249596(US9447038, 24)
Affinity DataIC50:  32nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249574(US9447038, 2)
Affinity DataIC50:  34nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249646(US9447038, 74)
Affinity DataIC50:  34nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166457(US9073853, 16)
Affinity DataIC50:  35nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166456(US9073853, 15)
Affinity DataIC50:  37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166445(US9073853, 4)
Affinity DataIC50:  37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249717(US9447038, 145 | US9447038, 177)
Affinity DataIC50:  38nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166448(US9073853, 7)
Affinity DataIC50:  38nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249699(US9447038, 127)
Affinity DataIC50:  38nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249598(US9447038, 26)
Affinity DataIC50:  39nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249761(US9447038, 189)
Affinity DataIC50:  40nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249587(US9447038, 15)
Affinity DataIC50:  40nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249612(US9447038, 40)
Affinity DataIC50:  40nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249572(US9447038, 1)
Affinity DataIC50:  41nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249595(US9447038, 23)
Affinity DataIC50:  42nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166474(US9073853, 33)
Affinity DataIC50:  42nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249703(US9447038, 131)
Affinity DataIC50:  42nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249713(US9447038, 141)
Affinity DataIC50:  43nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249616(US9447038, 44)
Affinity DataIC50:  43nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166458(US9073853, 17)
Affinity DataIC50:  44nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249609(US9447038, 37 | US9447038, 38)
Affinity DataIC50:  45nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166517(US9073853, 76)
Affinity DataIC50:  45nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM166516(US9073853, 75)
Affinity DataIC50:  45nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249656(US9447038, 84)
Affinity DataIC50:  45nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 362 total ) | Next | Last >>
Jump to: